We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$16.7M
(-13%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-20.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$12.7M |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$6.11M |
| 3 |
Natera
NTRA
|
+$3.96M |
| 4 |
CareDx
CDNA
|
+$3.05M |
| 5 |
Guardant Health
GH
|
+$1.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Blue Water Life Science Advisors held 9 positions worth $110M, down 13% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors withdrew a net $22.6M in Q3 2025, closing 2 positions and reducing 3 holdings. Its most notable exit was 10x Genomics, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Blue Water Life Science Advisors opened a new position in Tempus AI worth $5.84M.
- Blue Water Life Science Advisors's largest Q3 2025 buy was Tempus AI: 72,412 shares worth $5.84M.
- Blue Water Life Science Advisors's biggest Q3 2025 reduction was Natera, cutting an estimated $3.96M.
- Blue Water Life Science Advisors fully exited 10x Genomics in Q3 2025, selling an estimated $12.7M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $110M portfolio in Q3 2025.
- Blue Water Life Science Advisors opened 1 new position and closed 2 in Q3 2025.
- Blue Water Life Science Advisors's portfolio value fell 13% quarter-over-quarter to $110M.
Based on Blue Water Life Science Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.